Home > Pharmaceutical > Cancer

Cancer (716)

Diabetes (197)

Drug Delivery System (179)

Drug Discovery (1491)

Generic Drugs (150)

Infectious Disease (378)

Mental Disease (101)

Neurodegenerative Disease (217)

Obesity Treatment (40)

OTC Drug (119)

Pharmaceutical Companies (385)

Prescription Drugs (311)

Regulation (236)

Vaccines (150)

Veterinary Medicine (30)

Cancer Market Research Reports

We offer market research, industry forecasts, and business analysis in the Cancer as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter

Title Search

1 - 25 of 716 Products

Sort by

Display

Cancer Testing in Europe: Market Segment Forecasts and Supplier Shares Product code:233488
Published by	Venture Planning Group
Published	May 20, 2013	Content info
Price	US $ 12800

US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237419
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 6400

UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237418
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 3950

Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237417
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 3950

Japanese Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237416
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 4850

Italian Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237415
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 3950

German Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237414
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 3950

French Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers Product code:237413
Published by	Venture Planning Group
Published	May 16, 2013	Content info
Price	US $ 3950

Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270721
Published by	GlobalData
Published	May 15, 2013	Content info	50 Pages
Price	US $ 3495

Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270720
Published by	GlobalData
Published	May 15, 2013	Content info	54 Pages
Price	US $ 3495

Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270719
Published by	GlobalData
Published	May 15, 2013	Content info	54 Pages
Price	US $ 3495

Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270718
Published by	GlobalData
Published	May 15, 2013	Content info	54 Pages
Price	US $ 3495

Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270717
Published by	GlobalData
Published	May 15, 2013	Content info	56 Pages
Price	US $ 3495

Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Product code:270716
Published by	GlobalData
Published	May 15, 2013	Content info	53 Pages
Price	US $ 3495

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Product code:270517
Published by	Kalorama Information
Published	May 8, 2013	Content info	670 Pages
Price	US $ 4500

Cancer Monoclonal Antibody Partnering Terms and Agreements Product code:238158
Published by	Current Partnering, a division of Wildwood Ventures Limited
Published	May 8, 2013	Content info	583 Pages
Price	US $ 1995

Cancer Diagnostic Testing World Markets Product code:203885
Published by	Trimark Publications
Published	May 1, 2013	Content info	336 Pages
Price	US $ 3400

Anti-Tumor Drugs Markets in China Product code:100198
Published by	Asia Market Information & Development
Published	May 1, 2013	Content info	186 Pages
Price	US $ 2000

Lymphoma Treatment Drugs Markets in China Product code:86340
Published by	Asia Market Information & Development
Published	May 1, 2013	Content info	177 Pages
Price	US $ 2000

PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022 Product code:270714
Published by	GlobalData
Published	April 30, 2013	Content info	99 Pages
Price	US $ 4995

PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022 Product code:270709
Published by	GlobalData
Published	April 30, 2013	Content info	98 Pages
Price	US $ 4995

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 Product code:270708
Published by	GlobalData
Published	April 30, 2013	Content info	104 Pages
Price	US $ 4995

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022 Product code:270705
Published by	GlobalData
Published	April 30, 2013	Content info	117 Pages
Price	US $ 4995

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2013 Product code:263237
Published by	BioSeeker Group AB
Published	April 22, 2013	Content info
Price	US $ 2249

Viral Carcinogenesis Drug Pipeline Update 2013 Product code:263236
Published by	BioSeeker Group AB
Published	April 22, 2013	Content info
Price	US $ 2249

User Guide About Us Policies Site Map

Int'l: +1-860-674-8796 US: +1-866-353-3335 (Toll Free) | EU: +32-2-535-7543 | SG: +65-6223-2436